EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Symptomatic treatment of REM sleep behavior disorder (RBD): A consensus from the international RBD study group - Treatment and trials working group

Emmanuel H During, Roneil Malkani, Isabelle Arnulf, Dieter Kunz, Frederik Bes, Valerie Cochen De Cock, Pietro-Luca Ratti, Ambra Stefani, Mya C Schiess, Federica Provini, Carlos H Schenck, Aleksandar Videnovic

Sleep Medicine · 2025-08 · 132 · 106554

DOI: 10.1016/j.sleep.2025.106554 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Sleep Medicine, 2025-08. Verfasst von Emmanuel H During und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: emmanuel.during@mssm.edu. Hauptthemen laut MEDLINE: REM Sleep Behavior Disorder. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 99 Literaturangaben. Gefördert von: Sleep Research Society Foundation, Kleine-Levin Syndrome Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid-eye-movement sleep behavior disorder (RBD) is a parasomnia causing motor behaviors and vocalizations during sleep, which can lead to injuries in patients and their bed partners. Adult-onset RBD generally precedes a neurodegenerative synucleinopathy, while other cases can be associated with antidepressant use, neurotrauma and narcolepsy. The management of RBD relies on the systematic identification of etiologic and contributing factors, implementation of safety measures, appropriate pharmacotherapy and counseling, which should be patient-centered. In this manuscript, we summarize the evidence on the management of RBD. We summarize the evidence supporting the use of clonazepam, melatonin, rivastigmine, and pramipexole, the four agents currently recommended by the American Academy of Sleep Medicine. For each agent and for alternative therapies, we discuss efficacy, dosing, adverse effects and indications. We integrate the current knowledge on therapies in RBD in treatment algorithms that can guide providers in choosing the most appropriate initial therapy, and alternative options based on the course of symptoms and comorbidities. There is a large need for additional, well tolerated therapies for reducing RBD symptoms. The last section of this manuscript discusses current challenges and unmet needs, as well as future directions in developing therapies and improving the care of patients with RBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

REM Sleep Behavior DisorderHumansClonazepamMelatoninPramipexoleBenzothiazoles

Stichwörter der Autor:innen

CounselingDementiaLewy body diseaseMultiple system atrophyParkinson's diseaseREM sleep behavior disorderSafetySymptomaticTreatment

Substanzen

ClonazepamMelatoninPramipexoleBenzothiazoles

Autor:innen und Institutionen

  • Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: emmanuel.during@mssm.edu.
  • Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Assistance Publique Hôpitaux de Paris, Service des pathologies du Sommeil, Hôpital Pitié-Salpêtrière, Paris, France.
  • Department of Physiology, Charite, Universitätsmedizin, Berlin, Germany.
  • Sleep and Neurology Department, Beau Soleil Clinic and EuroMov, Digital Health in Motion, University of Montpellier, Montpellier, France.
  • Centre Hospitalier de l'Université de Montréal (CHUM) and CHUM Research Centre, Montréal, Canada.

Förderung

  • Sleep Research Society Foundation
  • Kleine-Levin Syndrome Foundation

Zitieren

APA

During, E. H., Malkani, R., Arnulf, I., Kunz, D., Bes, F., De Cock, V. C., Ratti, P. L., Stefani, A., Schiess, M. C., Provini, F., Schenck, C. H., & Videnovic, A. (2025). Symptomatic treatment of REM sleep behavior disorder (RBD): A consensus from the international RBD study group - Treatment and trials working group. Sleep Medicine, 132, 106554. https://doi.org/10.1016/j.sleep.2025.106554

Vancouver

During EH, Malkani R, Arnulf I, Kunz D, Bes F, De Cock VC, et al. Symptomatic treatment of REM sleep behavior disorder (RBD): A consensus from the international RBD study group - Treatment and trials working group. Sleep Medicine. 2025;132:106554. doi:10.1016/j.sleep.2025.106554

BibTeX
@article{During2025,
  author = {During, Emmanuel H and Malkani, Roneil and Arnulf, Isabelle and Kunz, Dieter and Bes, Frederik and De Cock, Valerie Cochen and Ratti, Pietro-Luca and Stefani, Ambra and Schiess, Mya C and Provini, Federica and Schenck, Carlos H and Videnovic, Aleksandar},
  title = {Symptomatic treatment of REM sleep behavior disorder (RBD): A consensus from the international RBD study group - Treatment and trials working group},
  journal = {Sleep Medicine},
  year = {2025},
  volume = {132},
  pages = {106554},
  doi = {10.1016/j.sleep.2025.106554}
}
Kostenlos starten →